Warning: The NCBI web site requires JavaScript to function. more...
Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.
Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH.
Malar J. 2008 Apr 28;7:72.
Related citations
Change in mutation patterns of Plasmodium vivax dihydrofolate reductase (Pvdhfr) and dihydropteroate synthase (Pvdhps) in P. vivax isolates from malaria endemic areas of Thailand.
Kuesap J, Rungsrihirunrat K, Thongdee P, Ruangweerayut R, Na-Bangchang K.
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:130-3.
Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bangs MJ, Sibley CH, Baird JK.
J Infect Dis. 2004 Feb 15;189(4):744-50. Epub 2004 Feb 4.
Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, Sibley CH.
Antimicrob Agents Chemother. 2005 Feb;49(2):733-40.
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S, Ménard D.
Malar J. 2008 Feb 26;7:35.
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M.
Malar J. 2007 Mar 9;6:28.
Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT, Bora H, Bharti PK, Saifi MA, Das MK, Dev V, Kumar A, Singh N, Dash AP, Das B, Wajihullah, Sharma YD.
Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. Epub 2006 Dec 28.
Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system.
Auliff AM, Adams JH, O'Neil MT, Cheng Q.
Antimicrob Agents Chemother. 2010 Sep;54(9):3927-32. Epub 2010 Jun 21.
Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Safi N, Butt W, Atta H, Djadid ND.
Malar J. 2010 Mar 14;9:75.
Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase.
Hawkins VN, Suzuki SM, Rungsihirunrat K, Hapuarachchi HC, Maestre A, Na-Bangchang K, Sibley CH.
Am J Trop Med Hyg. 2009 Aug;81(2):348-55.
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites.
Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ.
Mol Biol Evol. 2003 Sep;20(9):1526-36. Epub 2003 Jun 27.
Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B.
J Infect Dis. 2008 Aug 1;198(3):409-17.
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S, Ménard D.
Am J Trop Med Hyg. 2009 Jul;81(1):19-22.
Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
Kaur S, Prajapati SK, Kalyanaraman K, Mohmmed A, Joshi H, Chauhan VS.
Acta Trop. 2006 Feb;97(2):174-80. Epub 2005 Nov 23.
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Snounou G.
Antimicrob Agents Chemother. 2001 Nov;45(11):3122-7.
Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia.
Mita T, Tanabe K, Takahashi N, Tsukahara T, Eto H, Dysoley L, Ohmae H, Kita K, Krudsood S, Looareesuwan S, Kaneko A, Björkman A, Kobayakawa T.
Antimicrob Agents Chemother. 2007 Mar;51(3):1071-7. Epub 2007 Jan 8.
Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan.
Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Kakar Q, Atta H, Djadid ND.
Exp Parasitol. 2011 Jan;127(1):167-72. Epub 2010 Jul 23.
Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q.
Am J Trop Med Hyg. 2006 Oct;75(4):617-21.
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.
Hastings MD, Sibley CH.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13137-41. Epub 2002 Aug 27.
Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa.
Mita T, Tanabe K, Takahashi N, Culleton R, Ndounga M, Dzodzomenyo M, Akhwale WS, Kaneko A, Kobayakawa T.
J Antimicrob Chemother. 2009 Feb;63(2):252-5. Epub 2008 Nov 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on